G. Willis

发表

A differential PCR assay for the detection of c-erbB 2 amplification used in a prospective study of breast cancer.

J. Hadfield, B. Jennings, S. Worsley, 1997, Molecular pathology : MP.

The genetics of cholesteatoma. A systematic review using narrative synthesis

M. Bhutta, C. Philpott, P. Prinsley, 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

How folate metabolism affects colorectal cancer development and treatment; a story of heterogeneity and pleiotropy.

B. Jennings, G. Willis, 2015, Cancer letters.

A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England.

I. Fellows, B. Jennings, J. Wimperis, 1997, Blood cells, molecules & diseases.

Incidence of liver disease in people with HFE mutations

L. Skipper, I. Fellows, B. Jennings, 2000, Gut.

HFE mutations in the elderly.

I. Fellows, B. Jennings, J. Wimperis, 2003, Blood cells, molecules & diseases.

HFE mutations in an inflammatory arthritis population.

D. Scott, B. Jennings, M. Bukhari, 2002, Rheumatology.

Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes.

M. Sampson, R. Greenwood, B. Jennings, 2000, The Journal of laboratory and clinical medicine.

Haemochromatosis gene C282Y homozygotes in an elderly male population

I. Fellows, B. Jennings, J. Wimperis, 1999, The Lancet.

Do Novel Risk Biomarkers Reflect the Severity of Peripheral Arterial Disease?

M. Armon, B. Jennings, G. Willis, 2011, Angiology.

Haemochromatosis gene mutation in hepatocellular cancer

B. Jennings, G. Willis, R. Lonsdale, 1997, The Lancet.

Deaths attributed to haemochromatosis are rare in Britain

I. Fellows, J. Wimperis, G. Willis, 2000, BMJ : British Medical Journal.

Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.

R. Ball, I. Gibson, B. Jennings, 1993, Gynecologic oncology.

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

A. L. Tan, Sally J. Singh, C. Sudlow, 2021, The Lancet. Respiratory medicine.

Estimation of the 5-methyltetrahydrofolate apparent volume of distribution in humans.

P. Finglas, D. Barrett, Eid I. Brima, 2012, The Journal of nutrition.

The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family

M. Bhutta, Daniel Swan, C. Philpott, 2019, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.

P. Finglas, Y. Loke, M. Armon, 2009, Journal of vascular surgery.

Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study

I. Fellows, B. Jennings, J. Wimperis, 2005, BMC gastroenterology.

Iron absorption in male C282Y heterozygotes.

R. Foxall, A. Heath, M. Roe, 2005, The American journal of clinical nutrition.

Hepatocellular carcinoma and the penetrance of HFE C 282 Y mutations : a cross sectional study

I. Fellows, B. Jennings, J. Wimperis, 2005 .

Longevity and C282Y mutation for haemochromatosis: Survival of C282Y homozygotes does not preclude screening for HFE mutations

B. Jennings, J. Wimperis, G. Willis, 2003, BMJ : British Medical Journal.

Randomized clinical trial of folate supplementation in patients with peripheral arterial disease

M. Armon, B. Jennings, G. Willis, 2009, The British journal of surgery.